skip to contentNational Cancer Institute
National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Found 36 results for your search:
Relevant funding data is only available when one cancer type or one research topic is selected.
Fiscal Year FY 2012
NIH Funding Mechanism [K23]
Modify this Search New Search
Close

Modify Search Criteria

Some search criteria may be modified to refine your current search.

Select criteria to modify:

Add or remove search options:

Select criteria above to see additional search options

Cancel
Showing 1 - 36 of 36 results
Clipboard
Project Title Sorted ascending Project Number Funded Amount Principal
Investigator
Institution
1
Adherence to the HCT Medical Regimen: Influence of Cancer Patient-Cargiver Dyads 5K23CA149082-02 $106,276 POSLUSZNY, DONNA UNIVERSITY OF PITTSBURGH AT PITTSBURGH
2
Allogeneic stem cell transplant with grafts depleted of naive T cells for leukemi 5K23CA154532-02 $170,100 Bleakley, Marie FRED HUTCHINSON CANCER RESEARCH CENTER
3
Anti-Tumor Immunity in Response to a Modified Vaccine Strain Measles Virus 1K23CA159391-01A1 $164,160 Peikert, Tobias MAYO CLINIC
4
Bone Marrow Micrometastatic Disease in Ewing Sarcoma 5K23CA154530-02 $163,976 DuBois, Steven UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
5
Chemotherapy resistance in ALL: role of the bone marrow microenvironment 1K23CA158146-01A1 $174,960 Lin, Tara UNIVERSITY OF KANSAS MEDICAL CENTER
6
Childhood Cancer Survivor Program to Empower Action in Care (CC-SPEAC) 5K23CA124451-05 $140,361 Sharp, Lisa UNIVERSITY OF ILLINOIS
7
CT Volume Measurement of Lung Cancer treated with Erlotinib: Genomic Correlation 5K23CA157631-02 $180,360 Nishino, Mizuki BRIGHAM AND WOMEN'S HOSPITAL
8
Cyclophosphamide modified GM-CSF pancreatic tumor vaccine + listeria-mesothelin 1K23CA163672-01A1 $178,739 LE, DUNG JOHNS HOPKINS UNIVERSITY
9
Dissecting the mechanisms of immune tolerance within the pancreatic tumor's micro 5K23CA148964-03 $178,200 Zheng, Lei JOHNS HOPKINS UNIVERSITY
10
Effects of Antioxidant Supplementation during Breast Cancer Adjuvant Therapy 5K23CA141052-04 $152,763 GREENLEE, HEATHER COLUMBIA UNIVERSITY HEALTH SCIENCES
11
Enhancing T-Cell Responses with the Glutathione Mimetic NOV-002 in Breast Cancer 5K23CA148893-03 $159,652 MONTERO, ALBERTO UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
12
Epigenetic markers involved in colorectal cancer recurrence and metastases 5K23CA127141-05 $140,940 AHUJA, NITA JOHNS HOPKINS UNIVERSITY
13
Gene Modified Dendritic Cell Therapy in Lung Cancer 5K23CA131577-04 $132,031 Lee, Jay UNIVERSITY OF CALIFORNIA AT LOS ANGELES
14
Germline Telomere Biology Defects in Pediatric and Young Adult Acute Myeloid Leuk 1K23CA158148-01A1 $169,983 Gramatges, Maria BAYLOR COLLEGE OF MEDICINE
15
HIV, Gut Mucosal Turnover and Inflammation, and the Risk of Colorectal Neoplasia 5K23CA157929-02 $171,720 Somsouk, Ma UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
16
Homeostatic proliferation and regulatory T cell depletion as cancer immunotherapy 5K23CA133196-05 $129,843 Kline, Justin UNIVERSITY OF CHICAGO
17
Human Herpesvirus-8 Replication and Kaposi Sarcoma Response to Treatment 5K23CA150931-02 $143,339 Phipps, Warren FRED HUTCHINSON CANCER RESEARCH CENTER
18
Improving current therapies for myeloma 5K23CA130074-04 $172,368 VOGL, DAN UNIVERSITY OF PENNSYLVANIA
19
Inhibiting EGFR and ER pathways in NSCLC 5K23CA149079-02 $165,240 GARON, EDWARD UNIVERSITY OF CALIFORNIA AT LOS ANGELES
20
Metformin as a Novel Chemotheraeutic Strategy for the Treatment of Endometrial Ca 5K23CA143154-03 $170,873 Bae-Jump, Victoria UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
21
Methylation and Hepatocellular Carcinoma Outcomes 5K23CA149084-02 $170,790 Siegel, Abby COLUMBIA UNIVERSITY HEALTH SCIENCES
22
MicroRNA profiling to predict recurrence after resection of early lung cancer 5K23CA149076-02 $187,965 Yendamuri, Saikrishna ROSWELL PARK CANCER INSTITUTE CORP
23
mTOR Inhibition as a Therapeutic Strategy for Acute Myeloid Leukemia 5K23CA141054-03 $172,368 PERL, ALEXANDER UNIVERSITY OF PENNSYLVANIA
24
Nanoscale analysis of proteomic response to novel targeted therapies for lymphoma 5K23CA140722-03 $173,448 FAN, ALICE STANFORD UNIVERSITY
25
Novel Immunotherapeutic Approaches and Tools Utilizing Allogeneic T Cells 5K23CA129679-04 $177,525 SYMONS, HEATHER JOHNS HOPKINS UNIVERSITY
26
Novel Biologic Therapies for Hodgkin's Lymphoma 5K23CA124465-05 $140,940 KASAMON, YVETTE JOHNS HOPKINS UNIVERSITY
27
Novel systemic therapy to improve clinical outcome in small cell lung cancer 5K23CA164015-02 $163,298 Owonikoko, Taofeek EMORY UNIVERSITY
28
Optimizing localized therapy for primary liver cancer: a clinical trial and model 5K23CA139005-04 $169,560 Miksad, Rebecca BETH ISRAEL DEACONESS MEDICAL CENTER
29
PARP Inhibition to Treat Triple-Negative Breast Cancer Brain Metastases 5K23CA157728-02 $173,089 Anders, Carey UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
30
Radioguided Detection of Lymph Node Metastasis in Non-Small Cell Lung Cancer 5K23CA122182-05 $148,505 NWOGU, CHUKWUMERE ROSWELL PARK CANCER INSTITUTE CORP
31
Risk reduction through polyamine inhibition among colorectal carcinoma patients 5K23CA133142-04 $179,143 Zell, Jason UNIVERSITY OF CALIFORNIA IRVINE
32
Src inhibition in Colorectal Cancer 5K23CA136980-05 $134,796 KOPETZ, E UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
33
Targeted Therapies in Breast Cancer 5K23CA127469-04 $163,944 Mayer, Ingrid VANDERBILT UNIVERSITY MED CTR
34
Targeting Akt Activation in CLL 5K23CA160345-02 $167,400 Ding, Wei MAYO CLINIC
35
Targeting Leukemia Stromal Interactions in AML 5K23CA140707-04 $158,853 UY, GEOFFREY WASHINGTON UNIVERSITY
36
Therapeutic approaches that target cancer cell metabolism 5K23CA120862-05 $137,295 AMARAVADI, RAVI UNIVERSITY OF PENNSYLVANIA
Relevant funding data is only available when one cancer type or one research topic is selected.
Showing 1 - 36 of 36 results
Go to top